Valeria Kokitko

Valeria Kokitko

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2024 in Current issues in pharmacy and medicine: science and practice
Verified
Journal Article
Open access
PDF file
VKValeria Kokitko
Valeria Kokitko
VOV. M. Odyntsova
V. M. Odyntsova
Valeriana officinalis L. s.l. is a perennial herbaceous plant belonging to the Valerianaceae family. It is widely distributed in Ukraine and around the world. The official medicinal raw material derived from Valeriana officinalis consists of the dried, whole, or fragmented underground parts of the plant, including the rhizome along with the roots and stolons. To meet the standards outlined in the European Pharmacopoeia, this raw material must be standardized based on its essential oil content (a minimum of 4 ml/kg in dried preparations) and sesquiterpenic acids (a minimum of 0.17 percent by weight, calculated as valeric acid, in dried preparations). The aim of the work was searching, systematizing, and generalizing information from the specialized literature on the chemical composition, biological activity and therapeutic use of Valeriana officinalis. Valeriana officinalis has sedative, mild analgesic, hypnotic, antispasmodic, carminative, and hypotensive effects. Historically, it was used for hysterical conditions, hyperexcitability, insomnia, hypochondria, migraine, spasms, intestinal colic, rheumatic pains, dysmenorrhea, and especially for conditions accompanied by nervous excitability. The main classes of biological substances identified in Valeriana officinalis are valepotriates, iridolactones, alkaloids, phenolic acids, sesquiterpenes, flavonoids, terpene coumarins, lignans, terpene and flavonol glycosides. It has not yet been established which components of Valeriana officinalis are responsible for its pharmacological effects. Current opinion is that the overall effect of valerian is due to several different groups of components and their different mechanisms of action. Therefore, the activity of different preparations of valerian will depend on their content and concentration of several types of components. Conclusions. Summarized and systematized original works related to pharmacognostic study, phytochemical analysis, and medicinal use of underground and aerial parts of various species of Valeriana genus. The analysis of the material shows that in recent years, scientists from all over the world have paid attention to the above-ground part of valerian and have chosen it as an object of in-depth study. This approach opens new possibilities for the use of the herb Valeriana officinalis in medicine.

15 February 2022 in Current issues in pharmacy and medicine: science and practice
Verified
Journal Article
Open access
PDF file
VOV. M. Odyntsova
V. M. Odyntsova
VKV. H. Korniievska
V. H. Korniievska
SPS. V. Panchenko
S. V. Panchenko
YKYu. I. Korniievskyi
Yu. I. Korniievskyi
VKValeria Kokitko
Valeria Kokitko
ВКВ. І. Кокітко
В. І. Кокітко
Valerian Officinalis (Valeriana officinalis L.s.p.) is a collective species in Ukraine. It contains 13 species, including in the south of Ukraine grows valerian (V. stolonifera Czern.). At the present stage, it is confirmed that the calming and antispasmodic properties of valerian raw materials are due to the content of valepotriates, sesquiterpenoids and aromatic substances, in particular eugenol derivatives. That is why in many countries around the world a number of drugs have been created on their basis. The aim of our research is to determine the component composition of tinctures of tinctures of V. stolonifera Czern. made of 70 % alcohol and methanol using gas chromatography. Materials and methods. Raw materials (underground organs) Valerianae radices were harvested in March 2020 in Zaporizhzhia, Kantserivska Balka. Valerian tincture was prepared from fresh raw materials according to the method of making tinctures. The tincture was investigated on a gas chromatograph Agilent 7890B with mass spectrometric detector 5977B. The NIST14 mass spectrum library was used to identify the components. Results. 77 components were identified by gas chromatography in methanolic tincture of V. stolonifera Czern. roots, 13 components were isolated quantitatively. In the analysis of the chromatogram and the characteristic of the area of the peaks of the alcoholic tincture of V. stolonifera Czern. roots, 78 components were identified, 11 components were isolated quantitatively. At the comparative characteristic of chromatograms 39 components coincide. Of the main components, the largest content is: 13.413 RT methanolic 1(2H)-Naphthalenone, octahydro-4a,8a-dimethyl-7-(1-methylethyl)-, [4aR-(4a.α.,7.β.,8a.α.)] – 5.34 % 13.414 RT alcohol – 8.41 %; 11.943 RT methanolic Myrtenyl isovalerate – 3.88 %; 11,942 RT alcohol – 5.15 %; 15.362 RT methanolic Kessanyl acetate – 2.52 %; 15.360 RT Kessanyl acetate alcohol – 1.41 %. Conclusions. It was seen that valerian tinctures with methanol and alcohol extractant differ in both quantitative and qualitative composition analyzing the obtained data of gas chromatography. 39 Compounds were present in all tinctures; three of them were present in large quantities. According to the results of the study, data have been obtained that show that the best indicators of the quantitative and qualitative composition of the tincture of V. stolonifera Czern. were obtained using the extractant 70 % alcohol.

8 November 2024 in Current issues in pharmacy and medicine: science and practice
Verified
Journal Article
Open access
PDF file
VKValeria Kokitko
Valeria Kokitko
VOV. M. Odyntsova
V. M. Odyntsova
Plants of the Valeriana species are distributed in various parts of the world, especially in Europe and Asia. A high content of polyphenolic compounds, including flavonoids and hydroxycinnamic acids with expressed biological activity, was previously identified within the herb of the studied Valeriana species. Morphological and anatomical data can be used in phylogenetics of species and genera to find out diagnostic and age-related characteristics of plants. This led us to microscopic studies of aerial organs of the above-mentioned Valeriana species. The aim of the work is to conduct a comparative study of the diagnostic features within the morphological and anatomical structure of Valeriana stolonifera and Valeriana collina leaves. Materials and methods. Both raw and dried plant material of V. stolonifera and V. collina was used for microscopic studies. Temporary micropreparations were made using generally accepted methods. The anatomical features of the raw material were examined using Carl ZEISS “AxioStar Plus” and “Primo Star”. Results. The study identified key morphological and anatomical features of the species, which should be considered for the identification and standardization of promising medicinal plant materials and within the development of methods of analytical and regulatory documentation. Conclusions. The key microscopic differences in the leaves of the studied species lie in the structure of the adaxial and abaxial surfaces of the leaf blade. The upper epidermis consists of large elongate cells with wavy walls. The cells of the lower epidermis are smaller and have more sinuous walls compared to the upper epidermis cells. The degree of wall sinuosity varies between species – V. collina is characterized by more sinuous cells in both the upper and lower epidermis compared to V. stolonifera. The absence of stomata on the upper epidermis is a common feature for both species.

16 March 2026 in Current issues in pharmacy and medicine: science and practice
Verified
Journal Article
Open access
VKValeria Kokitko
Valeria Kokitko
VOV. M. Odyntsova
V. M. Odyntsova
The aerial parts of Valeriana collina and Valeriana stolonifera are considered a promising source of bioactive compounds with antimicrobial and hepatoprotective properties; however, their pharmacological characteristics have not been sufficiently studied. The aim of the work. To comprehensively evaluate the antimicrobial / antifungal potential, acute toxicity, and hepatoprotective activity of thick extracts from the herbs of V. collina and V. stolonifera. Materials and methods. Antimicrobial activity was determined by the agar diffusion method (well method). Acute toxicity was evaluated in Wistar rats according to OECD guidelines. Hepatoprotective activity was studied in a paracetamol-induced hepatitis model by measuring alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) levels; silymarin was used as the reference drug. Results. Both extracts exhibited a broad spectrum of antimicrobial activity; V. stolonifera was more effective against P. aeruginosa (p = 0.0113), while V. collina showed higher activity against C. albicans (p = 0.0080). Both samples were classified as low-toxicity (GHS Category 5). In the hepatitis model, V. stolonifera significantly reduced ALT, AST, and ALP levels, being not inferior – and in the case of ALP, superior – to silymarin. Conclusions. Both thick extracts of V. collina and V. stolonifera demonstrated pronounced antimicrobial activity against gram-positive and gram-negative bacteria as well as C. albicans. V. stolonifera was more effective against P. aeruginosa, whereas V. collina showed higher activity against C. albicans. These differences may be associated with variations in the ratios of biologically active compounds within the extracts, supporting the need for further chemical and pharmacological studies to elucidate mechanisms of action. A 20 % aqueous solution of the thick extract of V. collina administered intragastrically can be classified as toxicity class 5, with an LD50 ranging from 2000–5000 mg/kg. The solution of the thick extract of V. stolonifera caused no mortality in rats, classifying it as a substance with low acute toxicity (GHS Category 5, LD50 ≥5000 mg/kg). Further testing of the studied samples is not recommended unless specifically required for regulatory purposes. The studied valerian extracts, especially V. stolonifera, exhibited an expressed hepatoprotective effect in a paracetamol-induced hepatitis model in rats. The paracetamol-induced hepatitis led to marked biochemical and morphological signs of liver damage in rats. The V. stolonifera extract demonstrated a clear hepatoprotective effect, evidenced by reduced ALT, AST, and ALP levels and a decrease in the necrotic area of the liver. The effectiveness of the V. stolonifera extract exceeded that of the reference drug, silymarin.